Scioderm, Inc.

Calculating rank

USPTO Granted Patents = 6

% Expired Patents = 66.7

Forward Citations = 6

Loading Chart...

2 inventors (with patents filed for the assignee):

Elliott Farber (6 out of 13 patents)

Robert Ryan (2 out of 2 patents)

6 patents: Sort by Forward Citations

1. 9339492 - Methods of treating psoriasis using allantoin (2016-05-17),

2. 9095574 - Methods of treating psoriasis using allantoin (2015-08-04),

3. 9084780 - Allantoin-containing skin cream (2015-07-21),

4. 8877790 - Allantoin-containing skin cream (2014-11-04),

5. 8877789 - Allantoin-containing skin cream (2014-11-04),

6. 8877788 - Allantoin-containing skin cream (2014-11-04),

Company Overview

Scioderm, Inc. is a biopharmaceutical company focused on developing innovative therapies for rare, genetic skin disorders. Their lead product candidate, Zorblisa, is being developed for the treatment of epidermolysis bullosa, a devastating skin condition with no approved treatments. Scioderm is dedicated to improving the lives of patients with rare skin disorders through cutting-edge research and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#111 in Durham, NC

#982 in North Carolina

#45,030 in US

Durham, NC, United States of America

Scioderm, Inc.

Forward Citations = 6

2 inventors:

Elliott Farber (6 out of 13 patents)

Robert Ryan (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Scioderm, Inc.. Retrieved from https://idiyas.com/company/scioderm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]